161 related articles for article (PubMed ID: 22937733)
1. The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature.
Chen P; Zhao L; Zou P; Xu H; Lu A; Zhao P
BMC Cancer; 2012 Sep; 12():383. PubMed ID: 22937733
[TBL] [Abstract][Full Text] [Related]
2. Association between the ABCG2 C421A polymorphism and Alzheimer's disease.
Fehér Á; Juhász A; László A; Pákáski M; Kálmán J; Janka Z
Neurosci Lett; 2013 Aug; 550():51-4. PubMed ID: 23827224
[TBL] [Abstract][Full Text] [Related]
3. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.
Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H
Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995
[TBL] [Abstract][Full Text] [Related]
5. [Association of ABCG2 gene C421A polymorphism and susceptibility of primary gout in Han Chinese males].
Li FG; Chu Y; Meng DM; Tong YW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):683-5. PubMed ID: 22161105
[TBL] [Abstract][Full Text] [Related]
6. The ABCG2 gene Q141K polymorphism contributes to an increased risk of gout: a meta-analysis of 2185 cases.
Qiu Y; Liu H; Qing Y; Yang M; Tan X; Zhao M; Lin M; Zhou J
Mod Rheumatol; 2014 Sep; 24(5):829-34. PubMed ID: 24499401
[TBL] [Abstract][Full Text] [Related]
7. High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?
El Mesallamy HO; Rashed WM; Hamdy NM; Hamdy N
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1359-65. PubMed ID: 24718721
[TBL] [Abstract][Full Text] [Related]
8. Association of ABCB1 and ABCG2 single nucleotide polymorphisms with clinical findings and response to chemotherapy treatments in Kurdish patients with breast cancer.
Ghafouri H; Ghaderi B; Amini S; Nikkhoo B; Abdi M; Hoseini A
Tumour Biol; 2016 Jun; 37(6):7901-6. PubMed ID: 26700668
[TBL] [Abstract][Full Text] [Related]
9. Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.
Gardner ER; Ahlers CM; Shukla S; Sissung TM; Ockers SB; Price DK; Hamada A; Robey RW; Steinberg SM; Ambudkar SV; Dahut WL; Figg WD
BJU Int; 2008 Dec; 102(11):1694-9. PubMed ID: 18710444
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.
Pollex EK; Anger G; Hutson J; Koren G; Piquette-Miller M
Drug Metab Dispos; 2010 May; 38(5):740-4. PubMed ID: 20159988
[TBL] [Abstract][Full Text] [Related]
11. [Meta-analysis on relationship between single nucleotide polymorphism of rs2231142 in ABCG2 gene and gout in East Asian population].
Wu L; He Y; Zhang D
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Nov; 36(11):1291-6. PubMed ID: 26850254
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk.
Li R; Miao L; Qin L; Xiang Y; Zhang X; Peng H; Mailamuguli ; Sun Y; Yao H
Int J Clin Exp Pathol; 2015; 8(9):9812-23. PubMed ID: 26617691
[TBL] [Abstract][Full Text] [Related]
13. ABCG2 C421A polymorphisms affect exposure of the epidermal growth factor receptor inhibitor gefitinib.
Sakamoto S; Sato K; Takita Y; Izumiya Y; Kumagai N; Sudo K; Hasegawa Y; Yokota H; Akamine Y; Okuda Y; Asano M; Takeda M; Sano M; Miura M; Nakayama K
Invest New Drugs; 2020 Dec; 38(6):1687-1695. PubMed ID: 32436059
[TBL] [Abstract][Full Text] [Related]
14. Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma.
Korenaga Y; Naito K; Okayama N; Hirata H; Suehiro Y; Hamanaka Y; Matsuyama H; Hinoda Y
Int J Cancer; 2005 Nov; 117(3):431-4. PubMed ID: 15906349
[TBL] [Abstract][Full Text] [Related]
15. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population.
Jiri M; Zhang L; Lan B; He N; Feng T; Liu K; Jin T; Kang L
Clin Rheumatol; 2016 Jan; 35(1):159-63. PubMed ID: 26506822
[TBL] [Abstract][Full Text] [Related]
17. A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer.
Campa D; Pardini B; Naccarati A; Vodickova L; Novotny J; Försti A; Hemminki K; Barale R; Vodicka P; Canzian F
Mutat Res; 2008 Oct; 645(1-2):56-60. PubMed ID: 18775442
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population.
Wang B; Miao Z; Liu S; Wang J; Zhou S; Han L; Meng D; Wang Y; Li C; Ma X
Hum Genet; 2010 Feb; 127(2):245-6. PubMed ID: 19921266
[No Abstract] [Full Text] [Related]
19. Association between ABCG2 Q141K polymorphism and gout risk affected by ethnicity and gender: a systematic review and meta-analysis.
Dong Z; Guo S; Yang Y; Wu J; Guan M; Zou H; Jin L; Wang J
Int J Rheum Dis; 2015 May; 18(4):382-91. PubMed ID: 25639607
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy.
Wu H; Liu Y; Kang H; Xiao Q; Yao W; Zhao H; Wang E; Wei M
Biomed Res Int; 2015; 2015():279109. PubMed ID: 26634205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
